Legend Biotech Corporation
LEGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $3,267,486 | $3,117,538 | $2,974,987 |
| - Cash | $278,893 | $266,661 | $441,702 | $286,749 |
| + Debt | $259,991 | $387,919 | $362,810 | $350,603 |
| Enterprise Value | – | $3,388,744 | $3,038,646 | $3,038,841 |
| Revenue | $272,330 | $255,058 | $195,053 | $186,522 |
| % Growth | 6.8% | 30.8% | 4.6% | – |
| Gross Profit | $157,024 | $157,067 | $123,709 | $112,600 |
| % Margin | 57.7% | 61.6% | 63.4% | 60.4% |
| EBITDA | -$33,194 | -$113,722 | -$88,870 | $52,459 |
| % Margin | -12.2% | -44.6% | -45.6% | 28.1% |
| Net Income | -$39,689 | -$125,380 | -$100,916 | $26,284 |
| % Margin | -14.6% | -49.2% | -51.7% | 14.1% |
| EPS Diluted | -0.44 | -1.36 | -1.1 | 0.28 |
| % Growth | 67.6% | -23.6% | -492.9% | – |
| Operating Cash Flow | $28,801 | -$13,042 | -$103,754 | -$82,078 |
| Capital Expenditures | -$5,005 | -$9,224 | -$2,002 | -$2,378 |
| Free Cash Flow | $23,796 | -$22,266 | -$105,756 | -$84,456 |